Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Staphylococcal phosphatidylglycerol antigens activate human T cells via CD1a.

Monnot GC. et al, (2022), Nat Immunol

CD1a promotes systemic manifestations of skin inflammation.

Hardman CS. et al, (2022), Nat Commun, 13

Dengue virus co-opts innate type 2 pathways to escape early control of viral replication.

Fonseka CL. et al, (2022), Commun Biol, 5

HLA-dependent variation in SARS-CoV-2 CD8+ T cell cross-reactivity with human coronaviruses.

Buckley PR. et al, (2022), Immunology

An immunodominant NP105-113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease.

Peng Y. et al, (2022), Nat Immunol, 23, 50 - 61

Phospholipase activity of Acyloxyacyl Hydrolase induces IL‐22‐producing CD1a‐autoreactive T cells in individuals with psoriasis

Singh R. et al, (2021), European Journal of Immunology

Surveillance of SARS-CoV-2 variants of concern by identification of single nucleotide polymorphisms in the spike protein by a multiplex real-time PCR.

Gomes L. et al, (2021), J Virol Methods, 300

British Association of Dermatologists guidelines for the management of people with chronic urticaria 2021.

Sabroe RA. et al, (2021), Br J Dermatol

Immune Responses to a Single Dose of the AZD1222/Covishield Vaccine at 16 Weeks in Individuals in Sri Lanka.

Jeewandara C. et al, (2021), J Immunol

Comparison of two assays to detect IgG antibodies to the receptor binding domain of SARS‑CoV‑2 as a surrogate marker for assessing neutralizing antibodies in COVID-19 patients.

Kamaladasa A. et al, (2021), Int J Infect Dis, 109, 85 - 89

EAACI Biologicals Guidelines-Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12-17 years old.

Agache I. et al, (2021), Allergy

Immune responses to a single dose of the AZD1222/Covishield vaccine in health care workers.

Jeewandara C. et al, (2021), Nat Commun, 12

Immune responses to a single dose of the AZD1222/Covishield vaccine at 16 weeks in individuals in Sri Lanka

Jeewandara C. et al, (2021)

HLA-dependent variation in SARS-CoV-2 CD8+ T cell cross-reactivity with human coronaviruses

Buckley PR. et al, (2021)

Antibody and T cell responses to Sinopharm/BBIBP-CorV in naïve and previously infected individuals in Sri Lanka

Jeewandara C. et al, (2021)

Comparison of kinetics of immune responses to SARS-CoV-2 proteins in individuals with varying severity of infection and following a single dose of the AZD1222

Jayathilaka D. et al, (2021)

Pre-existing asthma as a comorbidity does not modify cytokine responses and severity of COVID-19.

Luo J. et al, (2021), Allergy Asthma Clin Immunol, 17

CD1a selectively captures endogenous cellular lipids that broadly block T cell response.

Cotton RN. et al, (2021), J Exp Med, 218

Seroprevalence of SARS-CoV-2 infection in the Colombo Municipality region, Sri Lanka

Jeewandara C. et al, (2021)

Spatial transcriptomic characterization of COVID-19 pneumonitis identifies immune circuits related to tissue injury

Cross AR. et al, (2021)

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?